Skip to content

A Virtual Arm to Stop Smoking

A Virtual Arm to Stop Smoking. A Comparative Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00639093
Enrollment
91
Registered
2008-03-19
Start date
2008-03-31
Completion date
2009-06-30
Last updated
2012-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

cigarette smoking, psychoeducational and motivational program, virtual reality

Brief summary

The investigators reported in a pilot study presented at last year's Cybertherapy Conference (Girard & Turcotte, 2007) that using an action-cue exposure strategy in virtual reality (ACE-VR; crushing virtual cigarettes) might be useful in the treatment of tobacco addiction. The investigators are pursuing research in this area with a randomized control trial based on 90 smokers who will receive a brief psychosocial smoking cessation program (25 people are enrolled so far and we expect to finish the study before the conference). During the first four weeks of an eight-session psychoeducational and motivational program, all participants will be immersed in VR. During the immersions in VR, 45 of the participants will use a virtual arm to catch and crush virtual cigarettes. The other half of the sample will use the virtual arm to catch virtual fruits (control condition). The smoking frequency, and abstinence, will be assessed with a daily diary and exhaled carbon monoxide tests (the CO2 tests will provide an objective confirmation of the abstinence reported in the diaries). The success the program will be compared based on the number of subjects who quitted or reduced their smoking frequency. The severity of addiction will be assessed with two questionnaires, the Fagerstrom and the Horn tests. Craving and withdrawal effects will be measured with the Minnesota Nicotine Withdrawal Scale (MNWS) and the Brief Questionnaire of Smoking Urges (QSU-Brief) at the baseline and at the visits from weeks 1 through 4, 6, 12 and at the end of the program. Before the VR immersion, the Immersive Tendencies Questionnaire will be administered and after each VR session participants will fill two questionnaires addressing presence and cybersickness. The comparative impact of both treatments will be tested with repeated measures ANOVAs (and planned contrasts) with sufficient power to detect medium effect sizes. The main goal of our study is show that crushing virtual cigarettes can boost the impact of a behavioural program dedicated to cigarette addiction.

Detailed description

A detailed description is available, in French, by contacting stephane.bouchard@uqo.ca.

Interventions

BEHAVIORALpsychoeducational / motivational combined with crushing

All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, 45 of the participants will use a virtual reality arm to catch and crush virtual cigarettes (on a computer).

BEHAVIORALpsychoeducational / motivational combined with control

All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, the 45 participants in the control condition will use a virtual reality arm to catch and crush virtual fruits (on a computer).

Sponsors

Universite du Quebec en Outaouais
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* adult smoker * aged 18 - 65 * willing to stop smoking * at least 10 cigarettes per day in the last year

Exclusion criteria

* receiving concomitant treatment for smoking (e.g., patches or varenicline) * weight problems : Body Mass Index \< 15 kg or \> 45.5 kg * suffering from a mental disorder, such as major depression, schizophrenia, etc.

Design outcomes

Primary

MeasureTime frameDescription
Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.Weeks 1, 4, 6, 12, 24 and 12-month follow-upParticipants completed a daily diary to record the number cigarettes smoked during the day. No cigarette smoked during 7 days = abstinence. To be counted as real abstinence, the participant had to smoke zero cigarettes during four weeks and confirmed by zero nicoting in the unrine sample. Six measurement times were used to assess if zero cigarettes has been smoked in the last 4 weeks prior to the study (Week 1), during the first four weeks (Week 4 measurement point) and so on for a blok of four weeks ending at each measurement point (e.g., four weeks before the 12-month follow-up).

Secondary

MeasureTime frame
Tiffany's Urge to Smoke QuestionnaireWeeks 1, 4, 6, 12, 24 and 12-month follow-up

Countries

Canada

Participant flow

Recruitment details

Medical clinic in the province of Quebec.

Participants by arm

ArmCount
VR - Cigarettes
All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, 45 of the participants will use a virtual reality arm to catch and crush virtual cigarettes (on a computer).
45
VR - Balls (Control)
All participants will receive an eight-session psychoeducational and motivational program. During the first four weeks, all participants will be immersed in virtual reality (VR). During the immersions in VR, the 45 participants in the control condition will use a virtual reality arm to catch and crush virtual fruits (on a computer).
46
Total91

Baseline characteristics

CharacteristicVR - CigarettesVR - Balls (Control)Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
45 Participants46 Participants91 Participants
Nicotine addiction45 Participants46 Participants91 Participants
Region of Enrollment
Canada
45 participants46 participants91 participants
Sex: Female, Male
Female
25 Participants26 Participants51 Participants
Sex: Female, Male
Male
20 Participants20 Participants40 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 450 / 46
serious
Total, serious adverse events
0 / 450 / 46

Outcome results

Primary

Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.

Participants completed a daily diary to record the number cigarettes smoked during the day. No cigarette smoked during 7 days = abstinence. To be counted as real abstinence, the participant had to smoke zero cigarettes during four weeks and confirmed by zero nicoting in the unrine sample. Six measurement times were used to assess if zero cigarettes has been smoked in the last 4 weeks prior to the study (Week 1), during the first four weeks (Week 4 measurement point) and so on for a blok of four weeks ending at each measurement point (e.g., four weeks before the 12-month follow-up).

Time frame: Weeks 1, 4, 6, 12, 24 and 12-month follow-up

ArmMeasureValue (NUMBER)
VR - CigarettesSelf-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.45 participants
VR - Balls (Control)Self-report Measure of Abstinence in the Last 7 Days, Averaged Over Four Weeks, and Confirmed by Urine Samples.46 participants
Secondary

Tiffany's Urge to Smoke Questionnaire

Time frame: Weeks 1, 4, 6, 12, 24 and 12-month follow-up

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026